170 related articles for article (PubMed ID: 23836502)
1. Imaging tumor growth non-invasively using expression of MagA or modified ferritin subunits to augment intracellular contrast for repetitive MRI.
Rohani R; Figueredo R; Bureau Y; Koropatnick J; Foster P; Thompson RT; Prato FS; Goldhawk DE
Mol Imaging Biol; 2014 Feb; 16(1):63-73. PubMed ID: 23836502
[TBL] [Abstract][Full Text] [Related]
2. Biophysical features of MagA expression in mammalian cells: implications for MRI contrast.
Sengupta A; Quiaoit K; Thompson RT; Prato FS; Gelman N; Goldhawk DE
Front Microbiol; 2014; 5():29. PubMed ID: 24550900
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of cells overexpressing MagA, an endogenous contrast agent for live cell imaging.
Goldhawk DE; Lemaire C; McCreary CR; McGirr R; Dhanvantari S; Thompson RT; Figueredo R; Koropatnick J; Foster P; Prato FS
Mol Imaging; 2009; 8(3):129-39. PubMed ID: 19723470
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal monitoring of stem cell grafts in vivo using magnetic resonance imaging with inducible maga as a genetic reporter.
Cho IK; Moran SP; Paudyal R; Piotrowska-Nitsche K; Cheng PH; Zhang X; Mao H; Chan AW
Theranostics; 2014; 4(10):972-89. PubMed ID: 25161700
[TBL] [Abstract][Full Text] [Related]
5. MagA expression attenuates iron export activity in undifferentiated multipotent P19 cells.
Liu L; Alizadeh K; Donnelly SC; Dassanayake P; Hou TT; McGirr R; Thompson RT; Prato FS; Gelman N; Hoffman L; Goldhawk DE
PLoS One; 2019; 14(6):e0217842. PubMed ID: 31170273
[TBL] [Abstract][Full Text] [Related]
6. The Effectiveness of Ferritin as a Contrast Agent for Cell Tracking MRI in Mouse Cancer Models.
Lee CW; Choi SI; Lee SJ; Oh YT; Park G; Park NY; Yoon KA; Kim S; Kim D; Kim YH; Suh JS
Yonsei Med J; 2017 Jan; 58(1):51-58. PubMed ID: 27873495
[TBL] [Abstract][Full Text] [Related]
7. Ovarian carcinoma: quantitative biexponential MR imaging relaxometry reveals the dynamic recruitment of ferritin-expressing fibroblasts to the angiogenic rim of tumors.
Vandsburger MH; Radoul M; Addadi Y; Mpofu S; Cohen B; Eilam R; Neeman M
Radiology; 2013 Sep; 268(3):790-801. PubMed ID: 23801774
[TBL] [Abstract][Full Text] [Related]
8. MRI reporter gene MagA suppresses transferrin receptor and maps Fe
Guan X; Yang B; Xie M; Ban DK; Zhao X; Lal R; Zhang F
Nanomedicine; 2019 Oct; 21():102064. PubMed ID: 31326524
[TBL] [Abstract][Full Text] [Related]
9. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
Cao M; Mao J; Duan X; Lu L; Zhang F; Lin B; Chen M; Zheng C; Zhang X; Shen J
Int J Cancer; 2018 Mar; 142(5):1033-1046. PubMed ID: 29047121
[TBL] [Abstract][Full Text] [Related]
10. MS-1 magA: Revisiting Its Efficacy as a Reporter Gene for MRI.
Pereira SM; Williams SR; Murray P; Taylor A
Mol Imaging; 2016; 15():. PubMed ID: 27118760
[TBL] [Abstract][Full Text] [Related]
11. MagA increases MRI sensitivity and attenuates peroxidation-based damage to the bone-marrow haematopoietic microenvironment caused by iron overload.
Shen Y; Zheng C; Tan Y; Jiang X; Li L
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S18-S27. PubMed ID: 30033763
[TBL] [Abstract][Full Text] [Related]
12. MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter.
Zurkiya O; Chan AW; Hu X
Magn Reson Med; 2008 Jun; 59(6):1225-31. PubMed ID: 18506784
[TBL] [Abstract][Full Text] [Related]
13. MRI-monitored intra-tumoral injection of iron-oxide labeled Clostridium novyi-NT anaerobes in pancreatic carcinoma mouse model.
Zheng L; Zhang Z; Khazaie K; Saha S; Lewandowski RJ; Zhang G; Larson AC
PLoS One; 2014; 9(12):e116204. PubMed ID: 25549324
[TBL] [Abstract][Full Text] [Related]
14. Bright ferritin for long-term MR imaging of human embryonic stem cells.
Zhuang K; Romagnuolo R; Sadikov Valdman T; Vollett KDW; Szulc DA; Cheng HM; Laflamme MA; Cheng HM
Stem Cell Res Ther; 2023 Nov; 14(1):330. PubMed ID: 37964388
[TBL] [Abstract][Full Text] [Related]
15. In Vivo magnetic resonance imaging of xenografted tumors using FTH1 reporter gene expression controlled by a tet-on switch.
He X; Cai J; Li H; Liu B; Qin Y; Zhong Y; Wang L; Liao Y
Oncotarget; 2016 Nov; 7(48):78591-78604. PubMed ID: 27732930
[TBL] [Abstract][Full Text] [Related]
16. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101.
Kiessling F; Farhan N; Lichy MP; Vosseler S; Heilmann M; Krix M; Bohlen P; Miller DW; Mueller MM; Semmler W; Fusenig NE; Delorme S
Neoplasia; 2004; 6(3):213-23. PubMed ID: 15153333
[TBL] [Abstract][Full Text] [Related]
18. Application of Benchtop-magnetic resonance imaging in a nude mouse tumor model.
Caysa H; Metz H; Mäder K; Mueller T
J Exp Clin Cancer Res; 2011 Jul; 30(1):69. PubMed ID: 21777437
[TBL] [Abstract][Full Text] [Related]
19. Investigating the Relationship between Transverse Relaxation Rate (R2) and Interecho Time in MagA-Expressing, Iron-Labeled Cells.
Lee CY; Thompson RT; Prato FS; Goldhawk DE; Gelman N
Mol Imaging; 2015; 14(12):551-60. PubMed ID: 26637544
[TBL] [Abstract][Full Text] [Related]
20. Folate-bovine serum albumin functionalized polymeric micelles loaded with superparamagnetic iron oxide nanoparticles for tumor targeting and magnetic resonance imaging.
Li H; Yan K; Shang Y; Shrestha L; Liao R; Liu F; Li P; Xu H; Xu Z; Chu PK
Acta Biomater; 2015 Mar; 15():117-26. PubMed ID: 25595473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
